183 related articles for article (PubMed ID: 19076826)
1. Inhibition of human immunodeficiency virus (HIV-1) infection in human peripheral blood leucocytes-SCID reconstituted mice by rapamycin.
Nicoletti F; Lapenta C; Donati S; Spada M; Ranazzi A; Cacopardo B; Mangano K; Belardelli F; Perno C; Aquaro S
Clin Exp Immunol; 2009 Jan; 155(1):28-34. PubMed ID: 19076826
[TBL] [Abstract][Full Text] [Related]
2. Human immunodeficiency virus type 1 strains R5 and X4 induce different pathogenic effects in hu-PBL-SCID mice, depending on the state of activation/differentiation of human target cells at the time of primary infection.
Fais S; Lapenta C; Santini SM; Spada M; Parlato S; Logozzi M; Rizza P; Belardelli F
J Virol; 1999 Aug; 73(8):6453-9. PubMed ID: 10400739
[TBL] [Abstract][Full Text] [Related]
3. Selective regulation of human immunodeficiency virus-infected CD4(+) lymphocytes by a synthetic immunomodulator leads to potent virus suppression in vitro and in hu-PBL-SCID mice.
Bahr GM; Darcissac EC; Castéran N; Amiel C; Cocude C; Truong MJ; Dewulf J; Capron A; Mouton Y
J Virol; 2001 Aug; 75(15):6941-52. PubMed ID: 11435574
[TBL] [Abstract][Full Text] [Related]
4. Identification of HIV-1 epitopes that induce the synthesis of a R5 HIV-1 suppression factor by human CD4+ T cells isolated from HIV-1 immunized hu-PBL SCID mice.
Yoshida A; Tanaka R; Kodama A; Yamamoto N; Ansari AA; Tanaka Y
Clin Dev Immunol; 2005 Dec; 12(4):235-42. PubMed ID: 16584108
[TBL] [Abstract][Full Text] [Related]
5. The human HIV/peripheral blood lymphocyte (PBL)-SCID mouse. A modified human PBL-SCID model for the study of HIV pathogenesis and therapy.
Boyle MJ; Connors M; Flanigan ME; Geiger SP; Ford H; Baseler M; Adelsberger J; Davey RT; Lane HC
J Immunol; 1995 Jun; 154(12):6612-23. PubMed ID: 7759895
[TBL] [Abstract][Full Text] [Related]
6. Glycosylphosphatidylinositol-Anchored Anti-HIV scFv Efficiently Protects CD4 T Cells from HIV-1 Infection and Deletion in hu-PBL Mice.
Ye C; Wang W; Cheng L; Li G; Wen M; Wang Q; Zhang Q; Li D; Zhou P; Su L
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881659
[TBL] [Abstract][Full Text] [Related]
7. In vivo analysis of Nef's role in HIV-1 replication, systemic T cell activation and CD4(+) T cell loss.
Watkins RL; Foster JL; Garcia JV
Retrovirology; 2015 Jul; 12():61. PubMed ID: 26169178
[TBL] [Abstract][Full Text] [Related]
8. Pertussis toxin B-oligomer inhibits HIV infection and replication in hu-PBL-SCID mice.
Lapenta C; Spada M; Santini SM; Racca S; Dorigatti F; Poli G; Belardelli F; Alfano M
Int Immunol; 2005 Apr; 17(4):469-75. PubMed ID: 15746245
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin reduces CCR5 density levels on CD4 T cells, and this effect results in potentiation of enfuvirtide (T-20) against R5 strains of human immunodeficiency virus type 1 in vitro.
Heredia A; Gilliam B; Latinovic O; Le N; Bamba D; Devico A; Melikyan GB; Gallo RC; Redfield RR
Antimicrob Agents Chemother; 2007 Jul; 51(7):2489-96. PubMed ID: 17485501
[TBL] [Abstract][Full Text] [Related]
10. Induction of protective immune responses against R5 human immunodeficiency virus type 1 (HIV-1) infection in hu-PBL-SCID mice by intrasplenic immunization with HIV-1-pulsed dendritic cells: possible involvement of a novel factor of human CD4(+) T-cell origin.
Yoshida A; Tanaka R; Murakami T; Takahashi Y; Koyanagi Y; Nakamura M; Ito M; Yamamoto N; Tanaka Y
J Virol; 2003 Aug; 77(16):8719-28. PubMed ID: 12885891
[TBL] [Abstract][Full Text] [Related]
11. A Simple Mouse Model for the Study of Human Immunodeficiency Virus.
Kim KC; Choi BS; Kim KC; Park KH; Lee HJ; Cho YK; Kim SI; Kim SS; Oh YK; Kim YB
AIDS Res Hum Retroviruses; 2016 Feb; 32(2):194-202. PubMed ID: 26564392
[TBL] [Abstract][Full Text] [Related]
12. Human immunodeficiency virus type 1 infection of neonatal severe combined immunodeficient mice xenografted with human cord blood cells.
Reinhardt B; Torbett BE; Gulizia RJ; Reinhardt PP; Spector SA; Mosier DE
AIDS Res Hum Retroviruses; 1994 Feb; 10(2):131-41. PubMed ID: 8198867
[TBL] [Abstract][Full Text] [Related]
13. Monitoring HIV DNA and cellular activation markers in HIV-infected humanized mice under cART.
Rochat MA; Schlaepfer E; Kuster SP; Li D; Audige A; Ivic S; Fahrny A; Speck RF
Virol J; 2018 Dec; 15(1):191. PubMed ID: 30558630
[TBL] [Abstract][Full Text] [Related]
14. T-cell dysfunctions in hu-PBL-SCID mice infected with human immunodeficiency virus (HIV) shortly after reconstitution: in vivo effects of HIV on highly activated human immune cells.
Rizza P; Santini SM; Logozzi MA; Lapenta C; Sestili P; Gherardi G; Lande R; Spada M; Parlato S; Belardelli F; Fais S
J Virol; 1996 Nov; 70(11):7958-64. PubMed ID: 8892919
[TBL] [Abstract][Full Text] [Related]
15. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.
Kaiser P; Joos B; Niederöst B; Weber R; Günthard HF; Fischer M
J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262
[TBL] [Abstract][Full Text] [Related]
16. Generation of cytotoxic T cells against virus-infected human brain macrophages in a murine model of HIV-1 encephalitis.
Poluektova LY; Munn DH; Persidsky Y; Gendelman HE
J Immunol; 2002 Apr; 168(8):3941-9. PubMed ID: 11937550
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-gamma c-/- (RAG-hu) mouse model.
Berges BK; Wheat WH; Palmer BE; Connick E; Akkina R
Retrovirology; 2006 Nov; 3():76. PubMed ID: 17078891
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of primary R5 human immunodeficiency virus type 1 clones in SCID-hu mice.
Scoggins RM; Taylor JR; Patrie J; van't Wout AB; Schuitemaker H; Camerini D
J Virol; 2000 Apr; 74(7):3205-16. PubMed ID: 10708437
[TBL] [Abstract][Full Text] [Related]
19. Regulation of human cell engraftment and development of EBV-related lymphoproliferative disorders in Hu-PBL-scid mice.
Wagar EJ; Cromwell MA; Shultz LD; Woda BA; Sullivan JL; Hesselton RM; Greiner DL
J Immunol; 2000 Jul; 165(1):518-27. PubMed ID: 10861091
[TBL] [Abstract][Full Text] [Related]
20. Vaginal transmission of HIV-1 in hu-SCID mice: a new model for the evaluation of vaginal microbicides.
Di Fabio S; Giannini G; Lapenta C; Spada M; Binelli A; Germinario E; Sestili P; Belardelli F; Proietti E; Vella S
AIDS; 2001 Nov; 15(17):2231-8. PubMed ID: 11698695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
